Patents by Inventor Il Ho HA

Il Ho HA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10632110
    Abstract: Provided are a pharmaceutical composition for preventing or treating cancer and a method of preventing or treating cancer using the same. Cancer may be effectively prevented or treated using the pharmaceutical composition and method.
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: April 28, 2020
    Assignee: MEDPACTO INC.
    Inventors: Il Ho Ha, Seong Jin Kim
  • Publication number: 20190175569
    Abstract: Provided are a pharmaceutical composition for preventing or treating cancer and a method of preventing or treating cancer using the same. Cancer may be effectively prevented or treated using the pharmaceutical composition and method.
    Type: Application
    Filed: February 19, 2019
    Publication date: June 13, 2019
    Applicant: MEDPACTO INC.
    Inventors: Il Ho HA, Seong Jin KIM
  • Patent number: 10265306
    Abstract: Provided are a pharmaceutical composition for preventing or treating cancer and a method of preventing or treating cancer using the same. Cancer may be effectively prevented or treated using the pharmaceutical composition and method.
    Type: Grant
    Filed: April 6, 2016
    Date of Patent: April 23, 2019
    Assignee: MEDPACTO INC.
    Inventors: Il Ho Ha, Seong Jin Kim
  • Patent number: 10259850
    Abstract: Provided are a modified DKK2 polypeptide according to an aspect, a nucleic acid encoding the same, a preparation method thereof, and use thereof. Accordingly, a modified DKK2 protein having an additional glycosyl group or improved binding affinity for a substrate LRP6 may be efficiently prepared, thereby being used for promoting angiogenesis or preventing or treating vascular permeability-related diseases.
    Type: Grant
    Filed: February 3, 2016
    Date of Patent: April 16, 2019
    Assignee: MEDPACTO INC.
    Inventors: Il Ho Ha, Seok Ho Yoo, Hye Nan Kim, Yeung Chul Kim, Ju Ry Lim
  • Publication number: 20180021317
    Abstract: Provided are a pharmaceutical composition for preventing or treating cancer and a method of preventing or treating cancer using the same. Cancer may be effectively prevented or treated using the pharmaceutical composition and method.
    Type: Application
    Filed: April 6, 2016
    Publication date: January 25, 2018
    Applicant: MEDPACTO INC.
    Inventor: Il Ho HA
  • Publication number: 20180016313
    Abstract: Provided are a modified DKK2 polypeptide according to an aspect, a nucleic acid encoding the same, a preparation method thereof, and use thereof. Accordingly, a modified DKK2 protein having an additional glycosyl group or improved binding affinity for a substrate LRP6 may be efficiently prepared, thereby being used for promoting angiogenesis or preventing or treating vascular permeability-related diseases.
    Type: Application
    Filed: February 3, 2016
    Publication date: January 18, 2018
    Applicant: MEDPACTO INC.
    Inventors: Il Ho HA, Seok Ho YOO, Hye Nan KIM, Yeung Chul KIM, Ju Ry LIM
  • Publication number: 20180008579
    Abstract: Provided are a pharmaceutical composition for preventing or treating chronic myeloid leukemia and a method of preventing or treating chronic myeloid leukemia using the same, thereby being effectively applied to the prevention or treatment of chronic myeloid leukemia.
    Type: Application
    Filed: January 21, 2016
    Publication date: January 11, 2018
    Applicant: MEDPACTO INC.
    Inventors: Il Ho HA, Kazuhito NAKA, Lee Young LEE